Cargando…

Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition

Poor nutrient transport through the cartilage endplate (CEP) is a key factor in the etiology of intervertebral disc degeneration and may hinder the efficacy of biologic strategies for disc regeneration. Yet, there are currently no treatments for improving nutrient transport through the CEP. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Mohamed, Hussien, Shayan, Jeon, Oju, Lotz, Jeffrey C., Wu, Peter I-Kung, Alsberg, Eben, Fields, Aaron J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008947/
https://www.ncbi.nlm.nih.gov/pubmed/36923455
http://dx.doi.org/10.3389/fbioe.2023.1111356
_version_ 1784905875246284800
author Habib, Mohamed
Hussien, Shayan
Jeon, Oju
Lotz, Jeffrey C.
Wu, Peter I-Kung
Alsberg, Eben
Fields, Aaron J.
author_facet Habib, Mohamed
Hussien, Shayan
Jeon, Oju
Lotz, Jeffrey C.
Wu, Peter I-Kung
Alsberg, Eben
Fields, Aaron J.
author_sort Habib, Mohamed
collection PubMed
description Poor nutrient transport through the cartilage endplate (CEP) is a key factor in the etiology of intervertebral disc degeneration and may hinder the efficacy of biologic strategies for disc regeneration. Yet, there are currently no treatments for improving nutrient transport through the CEP. In this study we tested whether intradiscal delivery of a matrix-modifying enzyme to the CEP improves solute transport into whole human and bovine discs. Ten human lumbar motion segments harvested from five fresh cadaveric spines (38–66 years old) and nine bovine coccygeal motion segments harvested from three adult steers were treated intradiscally either with collagenase enzyme or control buffer that was loaded in alginate carrier. Motion segments were then incubated for 18 h at 37 °C, the bony endplates removed, and the isolated discs were compressed under static (0.2 MPa) and cyclic (0.4–0.8 MPa, 0.2 Hz) loads while submerged in fluorescein tracer solution (376 Da; 0.1 mg/ml). Fluorescein concentrations from site-matched nucleus pulposus (NP) samples were compared between discs. CEP samples from each disc were digested and assayed for sulfated glycosaminoglycan (sGAG) and collagen contents. Results showed that enzymatic treatment of the CEP dramatically enhanced small solute transport into the disc. Discs with enzyme-treated CEPs had up to 10.8-fold (human) and 14.0-fold (bovine) higher fluorescein concentration in the NP compared to site-matched locations in discs with buffer-treated CEPs (p < 0.0001). Increases in solute transport were consistent with the effects of enzymatic treatment on CEP composition, which included reductions in sGAG content of 33.5% (human) and 40% (bovine). Whole disc biomechanical behavior—namely, creep strain and disc modulus—was similar between discs with enzyme- and buffer-treated CEPs. Taken together, these findings demonstrate the potential for matrix modification of the CEP to improve the transport of small solutes into whole intact discs.
format Online
Article
Text
id pubmed-10008947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100089472023-03-14 Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition Habib, Mohamed Hussien, Shayan Jeon, Oju Lotz, Jeffrey C. Wu, Peter I-Kung Alsberg, Eben Fields, Aaron J. Front Bioeng Biotechnol Bioengineering and Biotechnology Poor nutrient transport through the cartilage endplate (CEP) is a key factor in the etiology of intervertebral disc degeneration and may hinder the efficacy of biologic strategies for disc regeneration. Yet, there are currently no treatments for improving nutrient transport through the CEP. In this study we tested whether intradiscal delivery of a matrix-modifying enzyme to the CEP improves solute transport into whole human and bovine discs. Ten human lumbar motion segments harvested from five fresh cadaveric spines (38–66 years old) and nine bovine coccygeal motion segments harvested from three adult steers were treated intradiscally either with collagenase enzyme or control buffer that was loaded in alginate carrier. Motion segments were then incubated for 18 h at 37 °C, the bony endplates removed, and the isolated discs were compressed under static (0.2 MPa) and cyclic (0.4–0.8 MPa, 0.2 Hz) loads while submerged in fluorescein tracer solution (376 Da; 0.1 mg/ml). Fluorescein concentrations from site-matched nucleus pulposus (NP) samples were compared between discs. CEP samples from each disc were digested and assayed for sulfated glycosaminoglycan (sGAG) and collagen contents. Results showed that enzymatic treatment of the CEP dramatically enhanced small solute transport into the disc. Discs with enzyme-treated CEPs had up to 10.8-fold (human) and 14.0-fold (bovine) higher fluorescein concentration in the NP compared to site-matched locations in discs with buffer-treated CEPs (p < 0.0001). Increases in solute transport were consistent with the effects of enzymatic treatment on CEP composition, which included reductions in sGAG content of 33.5% (human) and 40% (bovine). Whole disc biomechanical behavior—namely, creep strain and disc modulus—was similar between discs with enzyme- and buffer-treated CEPs. Taken together, these findings demonstrate the potential for matrix modification of the CEP to improve the transport of small solutes into whole intact discs. Frontiers Media S.A. 2023-02-27 /pmc/articles/PMC10008947/ /pubmed/36923455 http://dx.doi.org/10.3389/fbioe.2023.1111356 Text en Copyright © 2023 Habib, Hussien, Jeon, Lotz, Wu, Alsberg and Fields. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Habib, Mohamed
Hussien, Shayan
Jeon, Oju
Lotz, Jeffrey C.
Wu, Peter I-Kung
Alsberg, Eben
Fields, Aaron J.
Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
title Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
title_full Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
title_fullStr Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
title_full_unstemmed Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
title_short Intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
title_sort intradiscal treatment of the cartilage endplate for improving solute transport and disc nutrition
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008947/
https://www.ncbi.nlm.nih.gov/pubmed/36923455
http://dx.doi.org/10.3389/fbioe.2023.1111356
work_keys_str_mv AT habibmohamed intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition
AT hussienshayan intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition
AT jeonoju intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition
AT lotzjeffreyc intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition
AT wupeterikung intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition
AT alsbergeben intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition
AT fieldsaaronj intradiscaltreatmentofthecartilageendplateforimprovingsolutetransportanddiscnutrition